Revenue of iX Biopharma Limited for specialty pharmaceutical segment 2016-2023
In financial year 2023, iX Biopharma Limited generated revenue of 5.2 million Singapore dollars from its specialty pharmaceutical segment. This segment focuses on the development, manufacturing, and sale of pharmaceutical products.